{
    "id": 3851,
    "fullName": "PIK3CA M1043I",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA M1043I lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). M1043I confers a gain of function on the Pik3ca protein as indicated by in increased phosphorylation of Akt, activation of downstream signaling, and transformation in cell culture (PMID: 17376864, PMID: 29533785).",
            "references": [
                {
                    "id": 101,
                    "pubMedId": 17376864,
                    "title": "Rare cancer-specific mutations in PIK3CA show gain of function.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17376864"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "M1043I",
    "createDate": "03/18/2015",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": {
        "id": 171972,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179234286G>C",
        "cDna": "c.3129G>C",
        "protein": "p.M1043I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17329,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I (SWOG S1400B) trial, Taselisib (GDC-0032) treatment did not meet primary endpoint in patients with lung squamous cell carcinoma harboring PIK3CA mutations, a patients harboring PIK3CA M1043I did not demonstrated response (PMID: 31158500; NCT02785913).",
            "molecularProfile": {
                "id": 3661,
                "profileName": "PIK3CA M1043I"
            },
            "therapy": {
                "id": 1016,
                "therapyName": "Taselisib",
                "synonyms": null
            },
            "indication": {
                "id": 3907,
                "name": "lung squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 15376,
                    "pubMedId": 31158500,
                    "title": "SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31158500"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20209,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II (NRG-GY008) trial, Aliqopa (copanlisib) was well tolerated but demonstrated limited efficacy, resulted in stable disease in a patient with endometrioid adenocarcinoma harboring PIK3CA M1043I (PMID: 31934607).",
            "molecularProfile": {
                "id": 3661,
                "profileName": "PIK3CA M1043I"
            },
            "therapy": {
                "id": 995,
                "therapyName": "Copanlisib",
                "synonyms": null
            },
            "indication": {
                "id": 2870,
                "name": "endometrial adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 17733,
                    "pubMedId": 31934607,
                    "title": "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31934607"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3661,
            "profileName": "PIK3CA M1043I",
            "profileTreatmentApproaches": [
                {
                    "id": 17261,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17259,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17262,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17260,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17256,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17255,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17258,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA M1043I"
                },
                {
                    "id": 17257,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA M1043I"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171973,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179234286G>C",
            "cDna": "c.3129G>C",
            "protein": "p.M1043I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171971,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179234286G>C",
            "cDna": "c.3129G>C",
            "protein": "p.M1043I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171972,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179234286G>C",
            "cDna": "c.3129G>C",
            "protein": "p.M1043I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}